Uriton is a trade name for a drug whose main ingredient is febuxostat, which has been widely used in recent years in patients with gout and hyperuricemia. Febuxostat is a drug that inhibits the production of uric acid, specifically, by inhibiting the production of uric acid to lower uric acid. It is mainly used for patients with excessive uric acid production or those who are not suitable for uric acid elimination drugs. Fibratesta was recommended as the first-line uric acid-lowering drug in the 2012 Gout Guidelines and in the 2016 China Gout Diagnosis and Treatment Guidelines. Febuxostat has advantages over allopurinol in terms of efficacy and safety.